326030 — SK Biopharmaceuticals Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapSucker Stock

Market Cap
KR₩8tn
Enterprise Value
KR₩8tn
Revenue
KR₩707bn

Annual balance sheet for SK Biopharmaceuticals Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	334,339	305,454	241,118	324,489	309,482
Net Total Accounts Receivable
Net Total Receivables	61,675	67,021	115,847	182,436	242,159
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	471,219	487,925	488,722	651,371	683,229
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	22,938	20,350	47,753	43,932	60,510
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	643,652	664,241	723,171	1,036,811	1,198,309
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	148,306	163,073	241,619	396,276	295,200
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	199,465	347,681	439,484	490,538	385,273
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	444,187	316,560	283,686	546,273	813,036
Total Liabilities & Shareholders' Equity	643,652	664,241	723,171	1,036,811	1,198,309
Total Common Shares Outstanding